Use of G-CSF mobilized bone marrow grafts in HLA-haploidentical related bone marrow transplantation (BMT) with post-transplantation cyclophosphamide (PT-CY)

被引：0
|
作者：
Nadira, D. [1 ,2 ]
Brian, M. J. [1 ]
Zinaida, P. [1 ,2 ]
Lana, D. [2 ]
Alen, O. [2 ]
Zorana, G. [3 ]
Ranka, S. S. [2 ]
Radovan, V. [1 ,2 ]
机构：
[1] Univ Zagreb, Sch Med, Zagreb, Croatia
[2] Univ Hosp Ctr Zagreb, Dept Internal Med, Div Hematol, Zagreb, Croatia
[3] Univ Hosp Ctr Zagreb, Tissue Typing Ctr, Zagreb, Croatia
来源：
BONE MARROW TRANSPLANTATION | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P056
引用
下载
收藏
页码：S147 / S148
页数：2
相关论文
共 50 条
  • [1] Use of G-CSF Mobilized Bone Marrow Grafts in HLA-haploidentical Bone Marrow Transplantation (BMT) with Post-transplantation Cyclophosphamide (PT-Cy) Decreases Risk of Severe Acute GVHD
    Durakovic, Nadira
    Peric, Zinaida
    Desnica, Lana
    Grubic, Zorana
    Romic, Lucija
    Serventi-Seiwerth, Ranka
    Vrhovac, Radovan
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 707 - 708
  • [2] HLA-haploidentical bone marrow transplantation with high-dose post-transplantation cyclophosphamide (Cy)
    Busca, A.
    Bruno, B.
    Giaccone, L.
    Festuccia, M.
    Testa, F.
    Allione, B.
    D'Ardia, S.
    Dellacasa, C.
    Pecoraro, C.
    Marmont, F.
    Falda, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S185 - S185
  • [3] Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
    Luznik, Leo
    O'Donnell, Paul V.
    Fuchs, Ephraim J.
    SEMINARS IN ONCOLOGY, 2012, 39 (06) : 683 - 693
  • [4] Use of G-CSF for Bone Marrow Graft Mobilization Increases NK Cell, Treg and iNKT Cell Graft Content, Possibly Lowering the Risk of Severe Acute Gvhd and Chronic Gvhd in HLA-Haploidentical Bone Marrow Transplantation (BMT) with Post-Transplantation Cyclophosphamide (PT-CY)
    Durakovic, Nadira
    Babic, Antonija
    Desnica, Lana
    Peric, Zinaida
    Seiwerth, Ranka Serventi
    Batinic, Drago
    Vrhovac, Radovan
    BLOOD, 2022, 140 : 7558 - 7559
  • [5] Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide
    Munchel, Ashley
    Kesserwan, Chimen
    Symons, Heather J.
    Luznik, Leo
    Kasamon, Yvette L.
    Jones, Richard J.
    Fuchs, Ephraim J.
    PEDIATRIC REPORTS, 2011, 3 : 43 - 47
  • [6] G-CSF primed bone marrow in HLA-haploidentical transplantation using post-transplantation cyclophosphamide (PTCY) could promote tolerance and further reduce risk of GVHD
    Durakovic, Nadira
    Peric, Zinaida
    Desnica, Lana
    Serventi-Seiwerth, Ranka
    Mikulic, Mirta
    Melamed, Brian
    Ostojic, Alen
    Pulanic, Drazen
    Roncevic, Pavle
    Grubic, Zorana
    Vrhovac, Radovan
    BONE MARROW TRANSPLANTATION, 2019, 54 : 571 - 572
  • [7] Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide
    Munchel, Ashley T.
    Kasamon, Yvette L.
    Fuchs, Ephraim J.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2011, 24 (03) : 359 - 368
  • [8] G-CSF primed bone marrow for allogeneic bone marrow transplantation (BMT).
    Massumoto, CM
    Campos, MF
    Mizukami, S
    Silva, LAG
    Romani, CR
    Callera, F
    Chamone, DF
    Dulley, F
    BLOOD, 1997, 90 (10) : 4238 - 4238
  • [9] HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide
    Fuchs, E. J.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S31 - S36
  • [10] HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide
    E J Fuchs
    Bone Marrow Transplantation, 2015, 50 : S31 - S36
12345